Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S S Agarwala

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Hematology/Oncology Clinics of North America|September 24, 1999
Adjuvant chemotherapy in head and neck cancerS S Agarwala
Expert Opinion on Investigational Drugs|June 27, 2001
Chemotherapy Foundation Symposium XVIII: Session on malignant melanomaS S Agarwala
The Medical Clinics of North America|January 1, 1996
Paraneoplastic syndromesS S Agarwala
Annals of Surgical Oncology|July 1, 1995
Potential uses of interferon alpha 2 as adjuvant therapy in cancerS S Agarwala, J M Kirkwood
Seminars in Surgical Oncology|May 20, 1998
Adjuvant therapy of melanomaS S Agarwala, J M Kirkwood
Oncology|March 1, 1994
Interferons in the therapy of solid tumorsS S Agarwala, J M Kirkwood
Current Opinion in Oncology|March 1, 1996
Interferons in melanomaS S Agarwala, J M Kirkwood
Expert Opinion on Biological Therapy|December 1, 2001
Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironmentS S Agarwala, M H Sabbagh
The Oncologist|May 5, 2000
Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanomaS S Agarwala, J M Kirkwood
Hematology/Oncology Clinics of North America|October 6, 1998
Adjuvant interferon treatment for melanomaS S Agarwala, J M Kirkwood
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Hematology/Oncology Clinics of North America|September 24, 1999
Adjuvant chemotherapy in head and neck cancerS S Agarwala
Expert Opinion on Investigational Drugs|June 27, 2001
Chemotherapy Foundation Symposium XVIII: Session on malignant melanomaS S Agarwala
The Medical Clinics of North America|January 1, 1996
Paraneoplastic syndromesS S Agarwala
Annals of Surgical Oncology|July 1, 1995
Potential uses of interferon alpha 2 as adjuvant therapy in cancerS S Agarwala, J M Kirkwood
Seminars in Surgical Oncology|May 20, 1998
Adjuvant therapy of melanomaS S Agarwala, J M Kirkwood
Oncology|March 1, 1994
Interferons in the therapy of solid tumorsS S Agarwala, J M Kirkwood
Current Opinion in Oncology|March 1, 1996
Interferons in melanomaS S Agarwala, J M Kirkwood
Expert Opinion on Biological Therapy|December 1, 2001
Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironmentS S Agarwala, M H Sabbagh
The Oncologist|May 5, 2000
Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanomaS S Agarwala, J M Kirkwood
Hematology/Oncology Clinics of North America|October 6, 1998
Adjuvant interferon treatment for melanomaS S Agarwala, J M Kirkwood
Pageof 3